{"id":"https://openalex.org/W3049539477","doi":"https://doi.org/10.23958/ijirms/vol05-i08/396","title":"Bevacizumab and Sorafenib Modulate P-Glycoprotein Function In Vitro and Bevacizumab Increases In Vivo Sorafenib Plasma Concentrations in Mice","display_name":"Bevacizumab and Sorafenib Modulate P-Glycoprotein Function In Vitro and Bevacizumab Increases In Vivo Sorafenib Plasma Concentrations in Mice","publication_year":2020,"publication_date":"2020-08-01","ids":{"openalex":"https://openalex.org/W3049539477","doi":"https://doi.org/10.23958/ijirms/vol05-i08/396","mag":"3049539477"},"language":"en","primary_location":{"id":"doi:10.23958/ijirms/vol05-i08/396","doi":"https://doi.org/10.23958/ijirms/vol05-i08/396","is_oa":true,"landing_page_url":"https://doi.org/10.23958/ijirms/vol05-i08/396","pdf_url":"https://www.ijirms.in/index.php/ijirms/article/download/396/655","source":{"id":"https://openalex.org/S4210174774","display_name":"International Journal of Innovative Research in Medical Science","issn_l":"2455-8737","issn":["2455-8737"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Innovative Research in Medical Science","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.ijirms.in/index.php/ijirms/article/download/396/655","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082741800","display_name":"Mahamadou Tandia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210164847","display_name":"H\u00f4pital Paul-Brousse","ror":"https://ror.org/05n7yzd13","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210164847","https://openalex.org/I4405259118"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Mahamadou Tandia","raw_affiliation_strings":["Laboratory of Pharmacology, Service Pharmacie, H\u00f4pital Paul Brousse AP-HP, 14 avenue Paul-Vaillant Couturier, 94800 Villejuif, France,\u00a0  UMR 935- Inserm Mod\u00e8les des cellules souches malignes et th\u00e9rapeutiques, institut Andr\u00e9 Lwoff, 94800 Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmacology, Service Pharmacie, H\u00f4pital Paul Brousse AP-HP, 14 avenue Paul-Vaillant Couturier, 94800 Villejuif, France,\u00a0  UMR 935- Inserm Mod\u00e8les des cellules souches malignes et th\u00e9rapeutiques, institut Andr\u00e9 Lwoff, 94800 Villejuif, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210097159","https://openalex.org/I4210164847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024805771","display_name":"Chadi Abbara","orcid":"https://orcid.org/0000-0002-8882-2441","observed_orcids":["https://orcid.org/0000-0002-8882-2441"]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210112910","display_name":"Centre Hospitalier Universitaire d'Angers","ror":"https://ror.org/0250ngj72","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210112910"]},{"id":"https://openalex.org/I4210164847","display_name":"H\u00f4pital Paul-Brousse","ror":"https://ror.org/05n7yzd13","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210164847","https://openalex.org/I4405259118"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Chadi Abbara","raw_affiliation_strings":["Laboratory of Pharmacology, Service Pharmacie, H\u00f4pital Paul Brousse AP-HP, 14 avenue Paul-Vaillant Couturier,   94800 Villejuif, France, Department of Pharmacology and Toxicology, Centre Hospitalier Universitaire d\u2019Angers, 4 rue Larrey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmacology, Service Pharmacie, H\u00f4pital Paul Brousse AP-HP, 14 avenue Paul-Vaillant Couturier,   94800 Villejuif, France, Department of Pharmacology and Toxicology, Centre Hospitalier Universitaire d\u2019Angers, 4 rue Larrey","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210112910","https://openalex.org/I4210164847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110155399","display_name":"Marie\u2010Sophie No\u00ebl\u2010Hudson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210164847","display_name":"H\u00f4pital Paul-Brousse","ror":"https://ror.org/05n7yzd13","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210164847","https://openalex.org/I4405259118"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marie-Sophie Noel-Hudson","raw_affiliation_strings":["Laboratory of Pharmacology, Service Pharmacie, H\u00f4pital Paul Brousse AP-HP, 14 avenue Paul-Vaillant Couturier,\u00a094800 Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmacology, Service Pharmacie, H\u00f4pital Paul Brousse AP-HP, 14 avenue Paul-Vaillant Couturier,\u00a094800 Villejuif, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210164847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074921926","display_name":"Dora Amor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210164847","display_name":"H\u00f4pital Paul-Brousse","ror":"https://ror.org/05n7yzd13","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210164847","https://openalex.org/I4405259118"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Dora Amor","raw_affiliation_strings":["Laboratory of Pharmacology, Service Pharmacie, H\u00f4pital Paul Brousse AP-HP, 14 avenue Paul-Vaillant Couturier,\u00a094800 Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmacology, Service Pharmacie, H\u00f4pital Paul Brousse AP-HP, 14 avenue Paul-Vaillant Couturier,\u00a094800 Villejuif, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210164847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062462789","display_name":"M\u00e9lanie Polrot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M\u00e9lanie Polrot","raw_affiliation_strings":["Animal and Veterinary Resources, IFR 54, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94800 Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Animal and Veterinary Resources, IFR 54, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94800 Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067275442","display_name":"Patrick Gonin","orcid":"https://orcid.org/0000-0001-6151-4580","observed_orcids":["https://orcid.org/0000-0001-6151-4580"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Patrick Gonin","raw_affiliation_strings":["Animal and Veterinary Resources, IFR 54, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94800 Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Animal and Veterinary Resources, IFR 54, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94800 Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071403576","display_name":"Laurence Bonhomme\u2010Faivre","orcid":"https://orcid.org/0000-0001-7460-7452","observed_orcids":["https://orcid.org/0000-0001-7460-7452"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210164847","display_name":"H\u00f4pital Paul-Brousse","ror":"https://ror.org/05n7yzd13","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210164847","https://openalex.org/I4405259118"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laurence Bonhomme-Faivre","raw_affiliation_strings":["Laboratory of Pharmacology, Service Pharmacie, H\u00f4pital Paul Brousse AP-HP, 14 avenue Paul-Vaillant Couturier, 94800 Villejuif, France,\u00a0  UMR 935- Inserm Mod\u00e8les des cellules souches malignes et th\u00e9rapeutiques, institut Andr\u00e9 Lwoff, 94800 Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmacology, Service Pharmacie, H\u00f4pital Paul Brousse AP-HP, 14 avenue Paul-Vaillant Couturier, 94800 Villejuif, France,\u00a0  UMR 935- Inserm Mod\u00e8les des cellules souches malignes et th\u00e9rapeutiques, institut Andr\u00e9 Lwoff, 94800 Villejuif, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210097159","https://openalex.org/I4210164847"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1981,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.50160117,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"5","issue":"08","first_page":"261","last_page":"267"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":1.0},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9959999918937683},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.9459999799728394},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.734000027179718},{"id":"https://openalex.org/keywords/doxorubicin-accumulation","display_name":"doxorubicin accumulation","score":0.8930000066757202},{"id":"https://openalex.org/keywords/drug-efflux","display_name":"drug efflux","score":0.4259999990463257},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.5440000295639038},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.796999990940094},{"id":"https://openalex.org/keywords/vegf-inhibition","display_name":"VEGF inhibition","score":0.6359999775886536}],"concepts":[{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.9502644538879395},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8656724095344543},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7331690788269043},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.710860013961792},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.5518695116043091},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.46255508065223694},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45409128069877625},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4292517900466919},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.31270381808280945},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23966392874717712},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.23647630214691162},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.18556034564971924},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.13349705934524536},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12983378767967224},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12951835989952087},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.23958/ijirms/vol05-i08/396","doi":"https://doi.org/10.23958/ijirms/vol05-i08/396","is_oa":true,"landing_page_url":"https://doi.org/10.23958/ijirms/vol05-i08/396","pdf_url":"https://www.ijirms.in/index.php/ijirms/article/download/396/655","source":{"id":"https://openalex.org/S4210174774","display_name":"International Journal of Innovative Research in Medical Science","issn_l":"2455-8737","issn":["2455-8737"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Innovative Research in Medical Science","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.23958/ijirms/vol05-i08/396","doi":"https://doi.org/10.23958/ijirms/vol05-i08/396","is_oa":true,"landing_page_url":"https://doi.org/10.23958/ijirms/vol05-i08/396","pdf_url":"https://www.ijirms.in/index.php/ijirms/article/download/396/655","source":{"id":"https://openalex.org/S4210174774","display_name":"International Journal of Innovative Research in Medical Science","issn_l":"2455-8737","issn":["2455-8737"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Innovative Research in Medical Science","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3049539477.pdf","grobid_xml":"https://content.openalex.org/works/W3049539477.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W1975002354","https://openalex.org/W1978047427","https://openalex.org/W2011021857","https://openalex.org/W2029789274","https://openalex.org/W2043021219","https://openalex.org/W2077902171","https://openalex.org/W2098142549","https://openalex.org/W2129866880","https://openalex.org/W2166153381","https://openalex.org/W2171945016","https://openalex.org/W2287293799","https://openalex.org/W2425406671","https://openalex.org/W2604333409","https://openalex.org/W2745803145","https://openalex.org/W2758002845"],"related_works":["https://openalex.org/W2782924389","https://openalex.org/W2126162318","https://openalex.org/W2171945016","https://openalex.org/W7095193804","https://openalex.org/W1975764972","https://openalex.org/W2093727844","https://openalex.org/W4409247014","https://openalex.org/W2095146403","https://openalex.org/W2002464886","https://openalex.org/W2045450498"],"abstract_inverted_index":{"Overexpression":[0],"of":[1,18,89,97,138,178,184,191],"P-glycoprotein":[2],"(P-gp)":[3],"is":[4,12,107],"associated":[5],"with":[6,120,148],"multidrug":[7],"resistance.":[8],"Since":[9],"sorafenib":[10,39,61,83,90,106,151,155,179,192,214],"(NEXAVAR\u00ae)":[11],"a":[13,28,100,118,132],"P-gp":[14,42,56,64,142,204],"(an":[15],"efflux":[16],"protein":[17],"ATP-binding":[19],"cassette":[20],"family)":[21],"substrate,":[22],"we":[23],"tested":[24],"whether":[25,79],"bevacizumab":[26,80,121,149,163,195,201],"(AVASTIN\u00ae),":[27],"monoclonal":[29],"antibody":[30],"directed":[31],"toward":[32],"VEGF":[33],"(Vascular":[34],"Endothelial":[35],"Growth":[36],"Factor)":[37],"and":[38,60,128,136,166,206,213],"could":[40,81],"modulate":[41],"functionality.":[43],"In":[44,73,130,153],"vitro":[45,131,212],"two":[46],"human":[47,101],"ovarian":[48],"carcinoma":[49,103],"cells":[50],"(IGROV1)":[51],"overexpressing":[52],"or":[53,116,150],"weakly":[54],"expressing":[55,143],"were":[57,66,91,146],"used.":[58],"Bevacizumab":[59],"effects":[62],"on":[63,112,125],"functionality":[65,205],"evaluated":[67],"by":[68,93],"measuring":[69],"doxorubicin":[70,134,139,208],"intracellular":[71,209],"accumulation.":[72],"vivo":[74],"study":[75],"was":[76,157,168],"to":[77],"document":[78],"modify":[82],"disposition":[84],"in":[85,95,141,162,172,181,211,217],"mice.":[86],"Therefore,":[87],"concentrations":[88,216],"determined":[92],"HPLC":[94],"plasma":[96,215],"mice":[98],"bearing":[99],"colorectal":[102],"xenograft":[104],"when":[105],"given":[108],"orally":[109],"(5":[110,122],"mg/kg)":[111],"day":[113],"4,":[114],"alone":[115],"after":[117,194],"pretreatment":[119,152,202],"mg/kg":[123],"IP)":[124],"days":[126],"1":[127],"3.":[129],"significant":[133],"accumulation":[135,210],"reversion":[137],"resistance":[140],"cell":[144],"lines":[145],"observed":[147],"vivo,":[154],"AUC":[156],"1.44":[158],"fold":[159,170],"significantly":[160],"higher":[161,171],"pretreated":[164],"group":[165],"Cmax":[167],"1.35":[169],"bevacizumab-pretreated":[173],"group.":[174],"Mean":[175],"residence":[176],"time":[177],"increased":[180],"the":[182],"presence":[183],"bevacizumab,":[185],"this":[186],"increase":[187],"reflects":[188],"an":[189],"improvement":[190],"bioavailability":[193],"pretreatment.":[196],"We":[197],"may":[198],"conclude":[199],"that":[200],"decreases":[203],"increases":[207],"vivo.":[218]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-09-07T09:17:50.787605","created_date":"2020-08-21T00:00:00"}